SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-273789
Filing Date
2017-08-31
Accepted
2017-08-31 09:23:35
Documents
3
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 6-K d449453d6k.htm 6-K 10773
2 EX-99.1 d449453dex991.htm EX-99.1 277842
3 GRAPHIC g449453jjj.jpg GRAPHIC 10546
  Complete submission text file 0001193125-17-273789.txt   304399
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 171062208
SIC: 2834 Pharmaceutical Preparations